Metacam (20 - 25 kg)
Active substance
ATC code
Species
Dogs
Indications
Alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders in dogs.
Dose to be administered and administration route
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day, which can be given orally or alternatively using Metacam 5 mg/ml solution for injection for dogs and cats.
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a maintenance dose of 0.1 mg meloxicam/kg body weight.
Each chewable tablet contains 1 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog.
Each chewable tablet can be halved for accurate dosing according to the individual body weight of the dog. Particular care should be taken with regard to the accuracy of dosing. To ensure a correct dosage, body weight should be determined as accurately as possible. The use of suitably calibrated measuring equipment is recommenended.
The veterinary medicinal product can be administered with or without food, are flavoured and are taken by most dogs voluntarily.
Dose scheme for the maintenance dose:
Body weight (kg) |
Number of chewable tablets |
mg/kg |
|
1 mg |
2.5 mg |
||
4.0–7.0 |
½ |
0.13–0.1 |
|
7.1– 10.0 |
1 |
0.14–0.1 |
|
10.1– 15.0 |
1½ |
0.15–0.1 |
|
15.1– 20.0 |
2 |
0.13–0.1 |
|
20.1– 25.0 |
1 |
0.12–0.1 |
|
25.1– 35.0 |
1 ½ |
0.15–0.1 |
|
35.1– 50.0 |
2 |
0.14–0.1 |
The use of Metacam oral suspension for dogs may be considered for an even more precise dosing. For dogs weighing less than 4 kg the use of Metacam oral suspension for dogs is recommended.
A clinical response is normally seen within 3–4 days. Treatment should be discontinued after 10 days if no clinical improvement is apparent.
Adverse reactions
Dogs:
Very rare (<1 animal / 10,000 animals treated, including isolated reports): |
Appetite loss1, lethargy1 Vomiting1, diarrhoea1, blood in faeces1,2, haemorrhagic diarrhoea1, haematemesis1, gastric ulcer1, small intestine ulcer1 Elevated liver enzymes1 Renal failure1 |
If adverse reactions occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Reporting adverse events is important. It allows continuous safety monitoring of a veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to either the marketing authorisation holder or its local representative or the national competent authority via the national reporting system. See the package leaflet for respective contact details.
Dispensing
POM-V - Prescription Only Medicine – Veterinarian
PRICE | Only for registered vets. Create a free profile to access all features.. Login |
---|---|
Art. Nr. | 04491/5020 |
EAN | 5012917010336 |